16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction.

      Cancer Cell

      Animals, Antigens, CD29, genetics, metabolism, Breast Neoplasms, pathology, Cell Division, Cell Transformation, Neoplastic, Female, Focal Adhesion Kinase 1, Focal Adhesion Protein-Tyrosine Kinases, Gene Targeting, Humans, Mammary Glands, Animal, anatomy & histology, growth & development, Mice, Mice, Transgenic, Neoplasm Transplantation, Protein-Tyrosine Kinases, Tumor Cells, Cultured

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Despite evidence demonstrating the role of beta1-integrin in the regulation of cancer cell proliferation in vitro, the importance of this cell adhesion receptor during the initiation and progression of epithelial tumors in vivo remains unclear. Here we have used the Cre/LoxP1 recombination system to disrupt beta1-integrin function in the mammary epithelium of a transgenic mouse model of human breast cancer. Using this approach, we show that beta1-integrin expression is critical for the initiation of mammary tumorigenesis in vivo, and for maintaining the proliferative capacity of late-stage tumor cells. These observations provide a direct demonstration that beta1-integrin plays a critical role in both the initiation and maintenance of mammary tumor growth in vivo.

          Related collections

          Author and article information

          Journal
          15324699
          10.1016/j.ccr.2004.06.025

          Comments

          Comment on this article